This inventor holds 3 USPTO granted patents. Top assignee: Adir Et Compagnie. Active years: 1992-1995.
Company Filing History:
Years Active: 1992-1995
Title: Innovations of Bernard Masereel: A Patent Portfolio in Medicinal Chemistry
Introduction
Bernard Masereel, based in Libin, Belgium, is a notable inventor with a focus on medicinal chemistry. With three patents to his name, he has made significant contributions to the field, particularly in the development of compounds aimed at addressing serious medical conditions. His work exemplifies the intersection of creativity and scientific inquiry.
Latest Patents
Among his latest innovations, one prominent patent involves pyridothiadiazines. This invention pertains to a compound defined by a specific formula, wherein A, R1, R2, and R4 play crucial roles in its effectiveness. This compound is particularly promising for treating conditions associated with dysfunctional glutamatergic neurotransmission.
Another noteworthy invention is a new pyridylsulphonylurea compound. This patent details a compound of a specific formula and its corresponding addition salts with pharmaceutically acceptable acids or bases. This pharmaceutical product holds potential for treating ischemic or hypoxic disorders, as well as peripheral and central edema.
Career Highlights
Bernard Masereel is affiliated with Adir Et Compagnie, a company that emphasizes innovation in the pharmaceutical sector. His extensive knowledge and expertise have allowed him to carve out a niche in the development of medicinal compounds. His commitment to advancing medical science through innovative solutions is evident in his patent portfolio.
Collaborations
Throughout his career, Masereel has worked alongside notable colleagues such as Bernard Pirotte and Jacques Delarge. These collaborations have fostered a creative environment where ideas can flourish, ultimately leading to impactful inventions and advancements in medicinal chemistry.
Conclusion
Bernard Masereel's contributions to the field of medicinal chemistry are marked by his innovative inventions and substantial patent portfolio. His latest work not only showcases his expertise but also reflects a dedication to improving health outcomes through scientifically backed medicinal products. As he continues to work with his team at Adir Et Compagnie, the potential for further groundbreaking innovations remains promising.